Close menu




March 18th, 2021 | 06:00 CET

Walt Disney, wallstreet:online, ProSiebenSat.1 Media

  • Investments
Photo credits: pixabay.com

What to do in the partial lockdown? People are increasingly asking for content to stay up to date or have some entertainment in dreary times. Whether it's video streaming, TV or reporting on the financial markets - the media industry is currently on the up. But to ensure that this does not remain a short-term corona effect, it is crucial to have promising business models. We present three shares and do the future check.

time to read: 3 minutes | Author: Nico Popp
ISIN: DE000A2GS609 , US7434762024 , DE000PSM7770

Table of contents:


    Walt Disney: Streaming and more

    When we think of Walt Disney, many of us have cartoon shows from the previous century in mind. But Disney is now a media company on the cutting edge. Through its streaming service, the world's third-largest media company scores with hot comic book adaptations as well as live sports and other content. In addition, there is an enormous pool of classic Disney content that even the older generation is familiar with. While competitors like Netflix have to spend billions of dollars on new content, Disney can more easily make offers to paying customers thanks to its vast archive.

    Disney's streaming service Disney+ is also expected to be rolled out more widely in Latin America and Asia in 2021 and should be well received by users given the diversity of its offerings. However, Walt Disney's stock has not always been convincing in recent months. The reason was weak figures from the theme parks that the Company operates and accounts for around a quarter of sales. Hopes of an end to the pandemic, especially in the US, have ensured that this division can even be seen as a source of hope again in the medium term. The share price rose by around 80% within a year. Given the potential of streaming services and the return to normality, the value remains promising.

    wallstreet:online: On the way to becoming a synergy world champion

    The wallstreet:online share continues to be regarded as a stock with great potential. The Company operates the platform of the same name, on which investors exchange views and discuss promising share titles daily. The news portal Finanznachrichten.de also belongs to the Company and is regarded by investors as the first port of call when following company news or researching other background information. More than a year ago, wallstreet:online launched a new business segment with its Smartbroker. The Smartbroker was cheaper than traditional providers but offered a high level of service. The first year exceeded all expectations: 80,000 customers recently traded with the Smartbroker. In 2021, the number could be more than twice as high.

    To this end, Matthias Hach, a proven brokerage expert, was recently engaged: E-Trade Deutschland, ViTrade, comdirect - wherever Hach has been so far, customer numbers have climbed or been high. At the Smartbroker, Hach wants to push ahead with developing its app and dovetail its broker even more closely with wallstreet:online's media offering. Customers should soon be able to trade directly from forums or news. Given the high user numbers and the incredible popularity of wallstreet:online's offerings, it is evident that such a step would be very beneficial to the Company's own brokerage business. wallstreet:online is both a top dog and a trendsetter. The Company has always been there. The brokerage business also ignited turbo growth in recent months. If the Company dovetails the two areas more closely, great potential should emerge. The stock has recently corrected a bit, but the upward trend looks like it has been painted.

    ProSieben.Sat.1 Media: More than just TV

    The stock of ProSiebenSat.1 Media also offers a clear upward trend. The Company has long been more than just a merger of two major TV stations. The business also includes the production of its content and e-commerce. The Company focuses particularly on online dating - a flourishing service, especially in times of a pandemic, and which promises lonely souls a flirt or two, at least without contact. An analyst recently commented that the share price did not adequately represent the valuation of this business alone. The share appears attractive given the low valuation and the upward trend established in recent months.

    Companies from the media industry have long since left structural change behind them. Business models are digital, and synergies are waiting to be leveraged in many areas. Above all, companies that combine different approaches and whose business is complementary without being dependent on each other are promising. Walt Disney and also ProSiebenSat.1 Media have done an excellent job in recent years, but wallstreet:online offers even more significant growth potential. The combination of stock market media and brokerage is simply ingenious.


    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may in the future hold shares or other financial instruments of the mentioned companies or will bet on rising or falling on rising or falling prices and therefore a conflict of interest may arise in the future. conflict of interest may arise in the future. The Relevant Persons reserve the shares or other financial instruments of the company at any time (hereinafter referred to as the company at any time (hereinafter referred to as a "Transaction"). "Transaction"). Transactions may under certain circumstances influence the respective price of the shares or other financial instruments of the of the Company.

    Furthermore, Apaton Finance GmbH reserves the right to enter into future relationships with the company or with third parties in relation to reports on the company. with regard to reports on the company, which are published within the scope of the Apaton Finance GmbH as well as in the social media, on partner sites or in e-mails, on partner sites or in e-mails. The above references to existing conflicts of interest apply apply to all types and forms of publication used by Apaton Finance GmbH uses for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and etc. on news.financial. These contents serve information for readers and does not constitute a call to action or recommendations, neither explicitly nor implicitly. implicitly, they are to be understood as an assurance of possible price be understood. The contents do not replace individual professional investment advice and do not constitute an offer to sell the share(s) offer to sell the share(s) or other financial instrument(s) in question, nor is it an nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but rather financial analysis, but rather journalistic or advertising texts. Readers or users who make investment decisions or carry out transactions on the basis decisions or transactions on the basis of the information provided here act completely at their own risk. There is no contractual relationship between between Apaton Finance GmbH and its readers or the users of its offers. users of its offers, as our information only refers to the company and not to the company, but not to the investment decision of the reader or user. or user.

    The acquisition of financial instruments entails high risks that can lead to the total loss of the capital invested. The information published by Apaton Finance GmbH and its authors are based on careful research on careful research, nevertheless no liability for financial losses financial losses or a content guarantee for topicality, correctness, adequacy and completeness of the contents offered here. contents offered here. Please also note our Terms of use.


    Der Autor

    Nico Popp

    Nico Popp

    At home in Southern Germany, the passionate stock exchange expert has been accompanying the capital markets for about twenty years. With a soft spot for smaller companies, he is constantly on the lookout for exciting investment stories.

    About the author



    Related comments:

    Commented by Carsten Mainitz on October 14th, 2026 | 05:30 CEST

    Tungsten, Weapons and Growth: Almonty, Rheinmetall and Deutz Under Review. Is This an Opportunity in a Megatrend?

    • Tungsten
    • Raw materials
    • Critical raw materials
    • Geopolitics
    • Defence industry
    • Armaments
    • Military
    • Supply chains
    • Investments

    The stock market is not linear. Greed and fear, excessive optimism or excessive scepticism—all of these drive markets. Only the future will tell what is cheap or expensive today. The stocks mentioned above are at precisely this point. Secure supply chains, access to raw materials and defence readiness are high on the agenda of Western governments. These long-term trends play strongly into the hands of defence companies and raw material producers. Almonty, in particular, as a producer of the critical raw material tungsten, holds a leading position in the sector. Where do the greatest opportunities lie for investors now?

    Read

    Commented by Carsten Mainitz on October 14th, 2026 | 05:25 CEST

    Who Profits When Patents Expire? The Billion-Euro Race Between Formycon, Fresenius and Pfizer

    • Biosimilar
    • FDA
    • Milestone
    • Cancer therapy
    • Pharma
    • Patents
    • Investments

    When patent protection for high-revenue biopharmaceuticals expires, a billion-euro market for follow-on products emerges. Michael Sen, head of the German healthcare group Fresenius SE, cites an impressive figure. By 2035, this could generate around EUR 180 billion in revenue. In particular, biosimilars, biotechnologically produced follow-on medicines that are highly similar in composition to the original medicine and equivalent in quality, efficacy and safety, are forecast to grow significantly. Moreover, biosimilars can strengthen competition and reduce treatment costs. Formycon stands out as a pure play. The company recently reached a crucial milestone. The US Food and Drug Administration (FDA) accepted the marketing authorisation application, the first publicly known application of its kind, for FYB206, a biosimilar candidate to the cancer medicine Keytruda, for review. Keytruda generates around USD 32 billion in annual revenue, making it the world's highest-revenue medicine. Fresenius is strengthening its positioning in the biosimilar sector through an acquisition. Pfizer needs new growth drivers. Who is best positioned for the year-end rally?

    Read

    Commented by Matthias Schomber on October 12th, 2026 | 05:24 CEST

    Every Crisis Creates an Opportunity: Nordex Stumbles, Jungheinrich Struggles, and RE Royalties Looks to Have Found a Bottom

    • Investments
    • Trading Opportunity
    • Technical Analysis
    • Rebound

    When market participants suddenly lose their nerve, and industrial heavyweights like Jungheinrich plunge to new multi-year lows despite bulging order books, a key question for private investors, among others, is whether this is a dangerous crisis with further downside ahead or an attractive entry opportunity. Nordex, too, has recently struggled to build on its successes from earlier this year. The share is trapped in a consolidation phase and has now returned to its level from late February, when it broke out upwards on high volume and with a long green weekly candlestick. Is this an attractive entry point for investors desperately seeking stable, high-yield alternatives in the future-oriented renewable energy market? Find out why scepticism could prevail regarding well-known German names and why a pioneer in royalty financing could be on the verge of the next major share price surge following a technical “textbook pattern”.

    Read